Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone, Surgery, and Orthodontics for Pediatric OSAHS and Malocclusion
NCT03451318Unknown
- Sponsor
- Shanghai Stomatological Hospital
- Start
- Mar 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mometasone furoate nasal spray in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by Shanghai Stomatological Hospital. Primary endpoint: Obstructive Apnea Index / Apnea Hypopnea Index at 2 years. Status: unknown.
02
Drugs
mometasone furoate nasal spray
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on NCT03451318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451318.